摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-bromonoscapine | 488721-01-3

中文名称
——
中文别名
——
英文名称
9-bromonoscapine
英文别名
9-bromo-α-noscapine;(S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,7-dimethoxyisobenzofuran-1(3H)-one;9′-bromonoscapine;(3S)-3-[(5R)-9-bromo-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-dimethoxy-3H-2-benzofuran-1-one
9-bromonoscapine化学式
CAS
488721-01-3
化学式
C22H22BrNO7
mdl
——
分子量
492.323
InChiKey
PLMUFLAOTAHIIZ-SJORKVTESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    169-170 °C(Solv: ethanol (64-17-5))
  • 沸点:
    595.4±50.0 °C(Predicted)
  • 密度:
    1.508±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    31
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    75.7
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    9-bromonoscapine 在 sodium azide 、 sodium iodide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 15.0h, 以100%的产率得到9-azido-α-noscapine
    参考文献:
    名称:
    以计算机为灵感设计和合成了一种新型微管蛋白结合抗癌药物:叶酸结合的那可品 (Targetin)。
    摘要:
    我们筛选不会解聚大量细胞微管的微管蛋白结合小分子,但基于众所周知的微管解聚秋水仙碱和鬼臼毒素的结构特征,揭示了那可碱的微管蛋白结合抗癌特性(Ye 等人在 Proc Natl Acad Sci美国 95:2280-2286, 1998)。在分子建模计算和构效关系的指导下,我们在诺斯卡品的 C9 处结合,叶酸基团 - 细胞叶酸受体 α (FRα) 的配体。FRα 在一些实体瘤如卵巢上皮癌中过度表达。分子对接实验预测,结合叶酸的那可品 (Targetin) 在 α- 和 β- 微管蛋白之间的界面处很好地容纳在结合腔内(对接分数 -11.295 kcal/mol)。Targetin 庞大的叶酸部分向微管腔延伸。基于分子力学能量最小化计算的结合自由能 (ΔG (bind)) 为 -221.01 kcal/mol,表明 Targetin 与受体之间存在良好的相互作用。化学合成、微管蛋白结合实验和体外抗
    DOI:
    10.1007/s10822-011-9508-z
  • 作为产物:
    描述:
    那可汀氢溴酸 作用下, 以 为溶剂, 以90%的产率得到9-bromonoscapine
    参考文献:
    名称:
    微管蛋白阻聚剂9-叠氮基-α-诺斯卡汀的合成及点击反应
    摘要:
    摘要 在温和的反应条件下(亚硝酸 叔 丁酯/叠氮化三甲基甲硅烷基叠氮化物在室温下),开发了一种由9-氨基-α-芥子 碱 2g 合成微管蛋白聚合抑制剂9-叠氮基-α-芥子碱 2h的有效方法 。该协议的优点是操作简单,产品产率高而不形成任何副产品。进一步的铜催化的9-叠氮基-α-芥子碱 2h 与炔烃 6a-f的 点击反应 产生了9-三唑基类胡萝卜素 7a-f, 产生了优异的收率。图形概要 开发了在温和的反应条件下由9-氨基-α-芥子碱合成9-叠氮基-α-芥子碱的友好协议;使用点击化学将其进一步衍生为三唑。
    DOI:
    10.1007/s11164-016-2773-7
  • 作为试剂:
    描述:
    那可汀 、 、 、 、 氢溴酸 在 9-Br 、 9-bromonoscapine 作用下, 反应 2.0h, 以to obtain 9-Br-nos (2) in 82% yield的产率得到9-bromonoscapine
    参考文献:
    名称:
    Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition
    摘要:
    本发明公开了用于治疗或预防传染病、抑制微生物在哺乳动物细胞内移动和抑制微生物复制能力的组合物和方法。该组合物包括各种诺斯卡平类似物,能够通过抑制细胞内的胞质转运机制,阻止病毒和其他微生物在哺乳动物和其他细胞内移动。本发明所描述的组合物包括所述诺斯卡平类似物的有效量,以及药学上可接受的载体或赋形剂。该组合物还可以包括一个或多个额外的抗微生物化合物。
    公开号:
    US20110274651A1
点击查看最新优质反应信息

文献信息

  • A Convenient Synthesis of Aryl-Substituted N-Carbamoyl/N-Thiocarbamoyl Narcotine and Related Compounds
    作者:Shefali Aggarwal、Narendra N. Ghosh、Ritu Aneja、Harish Joshi、Ramesh Chandra
    DOI:10.1002/1522-2675(200208)85:8<2458::aid-hlca2458>3.0.co;2-l
    日期:2002.8
    nornarcotine and 5-bromonornarcotine, synthesized from noscapine, with suitable aromatic isocyanates or isothiocyanates provides a general method for the synthesis of aryl-substituted N-carbamoyl or N-thiocarbamoylnarcotine and related compounds. Similarly, 15a has been prepared via the reduction of the lactone ring moiety of noscapine. Also, an improved procedure, which utilizes narcotine N-oxide⋅HCl
    由去甲烟碱合成的去甲可丁和5-溴去甲可丁与合适的芳族异氰酸酯或异硫氰酸酯的反应提供了合成芳基取代的N-氨基甲酰基或N-硫代氨基甲酰基那可丁和相关化合物的通用方法。类似地,通过还原诺斯卡品的内酯环部分制备了 15a。此外,还描述了一种改进的程序,该程序利用那可汀 N-氧化物·HCl 生成去甲可汀。
  • Metal-Free Activation of C(sp<sup>3</sup> )-H Bond, and a Practical and Rapid Synthesis of Privileged 1-Substituted 1,2,3,4-Tetrahydroisoquinolines
    作者:Santosh Kumar Choudhury、Pragati Rout、Bibhuti Bhusan Parida、Jean-Claude Florent、Ludger Johannes、Ganngam Phaomei、Emmanuel Bertounesque、Laxmidhar Rout
    DOI:10.1002/ejoc.201700471
    日期:2017.9.25
    reaction of cotarnine and acyl/aryl ketones in green solvents provides an efficient approach to an array of privileged 1,2,3,4-tetrahydroisoquinolines in excellent yields by metal free Activaion of C(SP3)-H bonds. This one-pot procedure takes place under base-free conditions at room temperature, and tolerates a wide range of functionalities. The reaction is highly chemo-selective, scalable in multi-gram
    Cotarnine 和酰基/芳基酮在绿色溶剂中的反应提供了一种有效的方法,通过 C(SP3)-H 键的无金属激活,以优异的收率获得一系列特权 1,2,3,4-四氢异喹啉。这种一锅程序在室温下无碱条件下进行,并具有广泛的功能。该反应具有高度化学选择性,可在多克规模上进行扩展,并且通过简单过滤分离出纯产物,无需后处理。有趣的是,从可塔宁卤化物盐的补充两步程序以良好的收率提供了曼尼希产品。范围详细说明了 9-溴可豆碱盐,以获取 9-溴香豆素启发的多种类似物。
  • Brominated Derivatives of Noscapine Are Potent Microtubule-interfering Agents That Perturb Mitosis and Inhibit Cell Proliferation
    作者:Jun Zhou、Kamlesh Gupta、Shefali Aggarwal、Ritu Aneja、Ramesh Chandra、Dulal Panda、Harish C. Joshi
    DOI:10.1124/mol.63.4.799
    日期:2003.4.1
    Noscapine, a microtubule-interfering agent, has been shown to arrest mitosis, to induce apoptosis, and to have potent antitumor activity. We report herein that two brominated derivatives of noscapine, 5-bromonoscapine (5-Br-nosc) and reduced 5-bromonoscapine (Rd 5-Br-nosc), have higher tubulin binding activity than noscapine and affect tubulin polymerization differently from noscapine. In addition, they are able to arrest cell cycle progression at mitosis at concentrations much lower than noscapine. Interestingly, whereas noscapine-arrested cells have nearly normal bipolar spindles, cells arrested by 5-Br-nosc and Rd 5-Br-nosc form multipolar spindles. Nevertheless, noscapine and the two derivatives all affect the attachment of chromosomes to spindle microtubules and they impair the tension across paired kinetochores to similar degrees. 5-Br-nosc and Rd 5-Br-nosc are also more active than noscapine in inhibiting the proliferation of various human cancer cells, including those that are resistant to paclitaxel and epothilone. Our results thus indicate a great potential for the use of 5-Br-nosc and Rd 5-Br-nosc both as biological tools for studying microtubule-mediated processes and as chemotherapeutic agents for the treatment of human cancers.
    去甲纳曲酮,一种微管干扰剂,已被证明能阻止有丝分裂,诱导细胞凋亡,并具有强效的抗肿瘤活性。本文报告了两种溴化的去甲纳曲酮衍生物,即5-溴去甲纳曲酮(5-Br-nosc)和还原型5-溴去甲纳曲酮(Rd 5-Br-nosc),它们与微管蛋白结合的活性高于去甲纳曲酮,并且影响微管蛋白聚合的方式与去甲纳曲酮不同。此外,它们能在比去甲纳曲酮低得多的浓度下阻止细胞周期在有丝分裂期的进展。有趣的是,尽管去甲纳曲酮阻止的细胞具有几乎正常的双极纺锤体,但5-Br-nosc和Rd 5-Br-nosc阻止的细胞形成了多极纺锤体。尽管如此,去甲纳曲酮及其两种衍生物都影响染色体与纺锤体微管的附着,并且它们对成对着丝粒间的张力损害程度相似。5-Br-nosc和Rd 5-Br-nosc在抑制多种人类癌细胞的增殖方面也比去甲纳曲酮更活跃,包括对紫杉醇和埃博霉素耐药的癌细胞。因此,我们的结果表明5-Br-nosc和Rd 5-Br-nosc具有巨大的潜力,既可作为研究微管介导过程的生物学工具,也可作为治疗人类癌症的化疗药物。
  • 2-(1-Benzotriazolyl)pyridine: A Robust Bidentate Ligand for the Palladium-Catalyzed CC (Suzuki, Heck, Fujiwara-Moritani, Sonogashira), CN and CS Coupling Reactions
    作者:Akhilesh K. Verma、Rajeev R. Jha、Ritu Chaudhary、Rakesh K. Tiwari、Abhinandan K. Danodia
    DOI:10.1002/adsc.201200583
    日期:2013.2.1
    designed and employed for the palladium-catalyzed CC (Suzuki, Heck, Fujiwara–Moritani, and Sonogashira), CN and CS coupling reactions. The ligand was found to be inexpensive, thermally stable, easy to synthesize from easily accessible starting materials on a multigram scale, show simplicity in use, and robustness in application, making this ligand effective for different coupling reactions. Suitably, the
    设计了一种新型的双齿配体1-(吡啶-2-基)-1 H-苯并[ d ] [1,2,3]三唑,并用于钯催化的CC(Suzuki,Heck,Fujiwara– Moritani和Sonogashira),CN和CS偶联反应。发现该配体便宜,热稳定,易于以几克规模由容易获得的起始原料合成,显示出使用简单性和在应用中的坚固性,从而使该配体对于不同的偶联反应有效。适当地,苯并三唑环的NN键的供体能力和吡啶环的N上的孤对电子增强了配体的二齿能力。
  • Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents
    作者:Amiya Kumar Patel、Rajesh Kumar Meher、Praveen Kumar Reddy、Ravi Kumar Pedapati、Pratyush Pragyandipta、Srinivas Kantevari、Manas Ranjan Naik、Pradeep Kumar Naik
    DOI:10.1016/j.jmgm.2021.107933
    日期:2021.7
    breast cancer cells isolated from patients. Interestingly, all these derivatives inhibited cellular proliferation in all the cancer cells that ranged between 6.2 to 38.9 μM, which is 6.7 to 1.5 fold lower than that of noscapine. Unlike previously reported derivatives of noscapine that arrests cells in the S-phase, these novel derivatives effectively inhibit proliferation of cancer cells, arrests cell
    基于我们在计算机上的努力,结合微管蛋白并显示出对一组乳腺癌细胞的抗癌活性,我们提出了一类新型的Noscapine衍生物,一种镇咳植物生物碱的1,3-二炔基-Noscapinoids,Noscapine 。结构活性分析指出,异喹啉环的C-9位置可以通过偶联1,3-二炔基结构基序进行修饰,以进行合理设计,并筛选出一系列具有较强耐受性的新型1,3-二炔基-类芥子油苷(20–22)与微管蛋白的结合亲和力。选定的1,3-二炔基-类胡萝卜素类化合物20-22预测的结合能提高了-6.568 kcal / mol,对于20为-7.367 kcal / mol,对于21为-7.922 kcal / mol,对于22为-7.922 kcal / mol。与铅分子(-5.246 kcal / mol)相比。这些新颖的衍生物是化学合成的,并基于使用两种人乳腺腺癌MCF-7和MDAMB-231以及从患者中分离出的一
查看更多

同类化合物

阿托喹啉 那可汀 那可丁N-氧化物 诺司卡品 盐酸盐 水合物 细果角茴香碱 紫堇明 盐酸那可丁一水合物 盐酸诺格考平 盐酸白毛莨碱 曲托喹啉 山缘草定碱 咖喏定 北美黄连碱 [S-(R*,R*)]-6,7-二甲氧基-3-(5,6,7,8-四氢-4-羟基-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基)苯酞 [6S,(+)]-6-[(1S)-1,2,3,4-四氢-6,7-二甲氧基-2-甲基异喹啉-1-基]呋喃并[3,4-e]-1,3-苯并二氧戊环-8(6H)-酮 7-氨基-4,5,6-三乙氧基-3-(6,7,8-三甲氧基-2-甲基-3,4-二氢-1H-异喹啉-1-基)-3H-2-苯并呋喃-1-酮 7-O-去甲基alpha-那可丁 6,7-二甲氧基-3-[(5R)-4-甲氧基-6-甲基-7,8-二氢-5H-[1,3]二氧杂环戊并[4,5-g]异喹啉-5-基]-3H-2-苯并呋喃-1-酮 3-异喹啉-1-基-3H-2-苯并呋喃-1-酮 (3S)-6,7-二甲氧基-3-[(5S)-6-甲基-5,6,7,8-四氢[1,3]二氧杂环戊并[4,5-g]异喹啉-5-基]-2-苯并呋喃-1(3H)-酮 (3S)-3-[(1R)-6,7-二羟基-8-甲氧基-2-甲基-3,4-二氢-1H-异喹啉-1-基]-6,7-二甲氧基-3H-2-苯并呋喃-1-酮 (-)-荷苞牡丹碱甲溴化物 (-)-荷苞牡丹碱 (-)-荷包牡丹碱甲溴化物 (-)-荷包牡丹碱甲氯化物 (-)-紫堇明 (+)-荷苞牡丹碱甲氯化物 (+)-荷包牡丹碱 hydrastidine isohydrastidine 5,9-bis-(4,5-dimethoxy-3-oxo-phthalan-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline (S,R)-9-bromo noscapine (S)-3-{(R)-9-[(2-chloro-acetylamino)-methyl]-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-6,7-dimethoxy-phthalide (S)-6,7-dimethoxy-3-{(R)-4-methoxy-6-methyl-9-[(2-morpholino-acetylamino)-methyl]-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-phthalide (R)-5-((S)-4,5-dimethoxy-3-oxo-phthalan-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline-9-carboxylic acid methyl ester 4-(((S)-1-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-5-methoxy-3-oxo-1,3-dihydroisobenzofuran-4-yl)oxy)butane-1-sulfonic acid ethyl 4-((5R)-5-((1S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)benzoate N-(3-((5R)-5-((1S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)phenyl)acetamide (S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-7-hydroxy-6-methoxyisobenzofuran-1(3H)-one ethyl 2-chloro-5-((5R)-5-((1S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)benzoate 3-(((S)-1-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-5-methoxy-3-oxo-1,3-dihydroisobenzofuran-4-yl)oxy)propane-1-sulfonic acid 4-(((S)-5-methoxy-1-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3-oxo-1,3-dihydroisobenzofuran-4-yl)oxy)butane-1-sulfonic acid (3S)-6,7-dimethoxy-3-((5R)-4-methoxy-6-methyl-9-(4-vinylphenyl)-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one (R)-5-((S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinoline-9-carbaldehyde N-desmethyl-N-carbethoxynarcotine (S)-3-((R)-9-bromo-4-methoxy-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,7-dimethoxyisobenzofuran-1(3H)-one 9-Fluoro-Noscapine 9-Nitro-Noscapine 7-benzyloxy-6-methoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one 7-benzyloxy-6-methoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one